Crohn's disease-derived monocytes fail to induce Paneth cell defensins

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 45, 2015, Pages 14000-14005

  Courth, Lioba F ^a   Ostaff, Maureen J ^b   Mailänder Sánchez, Daniela ^a   Malek, Nisar P ^a   Stange, Eduard F ^c   Wehkamp, Jan ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; BETA ACTIN; CYTOKINE; WNT PROTEIN; WNT1 PROTEIN; WNT3 PROTEIN; WNT3A PROTEIN; PRIMER DNA;

ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; HUMAN; HUMAN CELL; ILEUM; INNATE IMMUNITY; INTESTINE EPITHELIUM CELL; MONOCYTE; PANETH CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; UPREGULATION; WNT SIGNALING PATHWAY; GENETICS; HEK293 CELL LINE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MICROFLORA; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

ALPHA-DEFENSINS; CROHN DISEASE; DNA PRIMERS; HEK293 CELLS; HUMANS; ILEUM; IMMUNOHISTOCHEMISTRY; MICROBIOTA; MONOCYTES; PANETH CELLS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR CROSS-TALK; STATISTICS, NONPARAMETRIC;

EID: 84946762352     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1510084112     Document Type: Article

References (57)

1. Rosenstiel P, Sina C, Franke A, Schreiber S (2009) Towards a molecular risk map-recent advances on the etiology of inflammatory bowel disease. Semin Immunol 21(6):334-345.
2. Wehkamp J, Stange EF (2010) Paneth's disease. J Crohn's Colitis 4(5):523-531.
3. Wehkamp J, et al. (2005) Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci USA 102(50):18129-18134.
4. Wehkamp J, et al. (2004) NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 53(11):1658-1664.
5. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JPA (2004) Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: A metaanalysis. Am J Gastroenterol 99(12):2393-2404.
6. Hugot JP, et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411(6837):599-603.
7. Ogura Y, et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411(6837):603-606.
8. Koslowski MJ, et al. (2012) Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease. PLoS Genet 8(2):e1002523.
9. Koslowski MJ, et al. (2009) Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease. PLoS One 4(2):e4496.
10. Muise AM, et al. (2009) Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn's disease. Gut 58(8):1121-1127.
11. Cadwell K, et al. (2008) A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456(7219):259-263.
12. Hampe J, et al. (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39(2):207-211.
13. Adolph TE, et al. (2013) Paneth cells as a site of origin for intestinal inflammation. Nature 503(7475):272-276.
14. Kaser A, et al. (2008) XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 134(5):743-756.
15. Thachil E, et al. (2012) Abnormal activation of autophagy-induced crinophagy in Paneth cells from patients with Crohn's disease. Gastroenterology 142(5):1097-1099.e4.
16. Kaser A, Blumberg RS (2008) Paneth cells and inflammation dance together in Crohn's disease. Cell Res 18(12):1160-1162.
17. Andreu P, et al. (2005) Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine. Development 132(6):1443-1451.
18. van Es JH, et al. (2005) Wnt signalling induces maturation of Paneth cells in intestinal crypts. Nat Cell Biol 7(4):381-386.
19. Logan CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20(1):781-810.
20. Beisner J, et al. (2014) TCF-1-mediated Wnt signaling regulates Paneth cell innate immune defense effectors HD-5 and-6: Implications for Crohn's disease. Am J Physiol Gastrointest Liver Physiol 307(5):G487-G498.
21. Ikenoue T, et al. (2002) Analysis of the β-catenin/T cell factor signaling pathway in 36 gastrointestinal and liver cancer cells. Jpn J Cancer Res 93(11):1213-1220.
22. Bevins CL, Salzman NH (2011) Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol 9(5):356-368.
23. Ganesan K, et al. (2008) Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene. Cancer Res 68(11):4277-4286.
24. De Groote D, et al. (1992) Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 4(3):239-248.
25. Greaves M, Janossy G, Doenhoff M (1974) Selective triggering of human T and B lymphocytes in vitro by polyclonal mitogens. J Exp Med 140(1):1-18.
26. Gijsbers K, et al. (2004) CXCR1-binding chemokines in inflammatory bowel diseases: Down-regulated IL-8/CXCL8 production by leukocytes in Crohn's disease and selective GCP-2/CXCL6 expression in inflamed intestinal tissue. Eur J Immunol 34(7):1992-2000.
27. Jyonouchi H, Geng L, Cushing-Ruby A, Monteiro IM (2010) Aberrant responses to TLR agonists in pediatric IBD patients; the possible association with increased production of Th1/Th17 cytokines in response to candida, a luminal antigen. Pediatr Allergy Immunol 21(4 Pt 2):e747-e755.
28. Neurath MF (2014) Cytokines in inflammatory bowel disease. Nat Rev Immunol 14(5): 329-342.
29. Wehkamp J, et al. (2007) The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J Immunol 179(5):3109-3118.
30. Korinek V, et al. (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma. Science 275(5307):1784-1787.
31. Gustafson B, Smith U (2006) Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes. J Biol Chem 281(14):9507-9516.
32. Kaler P, Godasi BN, Augenlicht L, Klampfer L (2009) The NF-κB/AKT-dependent Induction of Wnt Signaling in Colon Cancer Cells by Macrophages and IL-1β. Cancer Microenviron 2(1):69-80.
33. Schwitalla S, et al. (2013) Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 152(1-2):25-38.
34. Chen M, et al. (2009) The anti-helminthic niclosamide inhibits Wnt/Frizzled1 signaling. Biochemistry 48(43):10267-10274.
35. Osada T, et al. (2011) Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations. Cancer Res 71(12):4172-4182.
36. Li Y, et al. (2014) Multi-Targeted therapy of cancer by niclosamide: A new application for an old drug. Cancer Lett 349(1):8-14.
37. Hsieh JC, et al. (1999) A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 398(6726):431-436.
38. Surmann-Schmitt C, et al. (2009)Wif-1 is expressed at cartilage-mesenchyme interfaces and impedes Wnt3a-mediated inhibition of chondrogenesis. J Cell Sci 122(Pt 20):3627-3637.
39. Simms LA, et al. (2008) Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut 57(7):903-910.
40. Caruso R, Warner N, Inohara N, Nuñez G (2014) NOD1 and NOD2: Signaling, host defense, and inflammatory disease. Immunity 41(6):898-908.
41. Leppkes M, Roulis M, Neurath MF, Kollias G, Becker C (2014) Pleiotropic functions of TNF-α in the regulation of the intestinal epithelial response to inflammation. Int Immunol 26(9):509-515.
42. Nava P, et al. (2010) Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways. Immunity 32(3):392-402.
43. Silva- García O, Valdez-Alarcón JJ, Baizabal-Aguirre VM (2014) The Wnt/β-catenin signaling pathway controls the inflammatory response in infections caused by pathogenic bacteria. Mediators Inflamm 2014:310183.
44. Gonther C, et al. (2011) Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. Nature 477(7364):335-339.
45. Cosín-Roger J, et al. (2013) M2 macrophages activate WNT signaling pathway in epithelial cells: Relevance in ulcerative colitis. PLoS One 8(10):e78128.
46. Pereira CP, Bachli EB, Schoedon G (2009) The wnt pathway: A macrophage effector molecule that triggers inflammation. Curr Atheroscler Rep 11(3):236-242.
47. Smith K, et al. (1999) Up-regulation of macrophage wnt gene expression in adenomacarcinoma progression of human colorectal cancer. Br J Cancer 81(3):496-502.
48. Farin HF, Van Es JH, Clevers H (2012) Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells. Gastroenterology 143(6):1518-1529.e7.
49. Gregorieff A, et al. (2005) Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology 129(2):626-638.
50. San Roman AK, Jayewickreme CD, Murtaugh LC, Shivdasani RA (2014) Wnt secretion from epithelial cells and subepithelial myofibroblasts is not required in the mouse intestinal stem cell niche in vivo. Stem Cell Rep 2(2):127-134.
51. Wahl LM, Wahl SM, Smythies LE, Smith PD (2006) Isolation of human monocyte populations. Curr Protoc Immunol Chapter 7:Unit 6A.
52. Fishbein T, et al. (2008) NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine. Gut 57(3):323-330.
53. Lough D, et al. (2012) Abnormal CX3CR1+ lamina propria myeloid cells from intestinal transplant recipients with NOD2 mutations. Am J Transplant 12(4):992-1003.
54. Sainathan SK, et al. (2008) Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis. Inflamm Bowel Dis 14(1):88-99.
55. Korzenik JR, Dieckgraefe BK, Valentine JF, Hausman DF, Gilbert MJ; Sargramostim in Crohn's Disease Study Group (2005) Sargramostim for active Crohn's disease. N Engl J Med 352(21):2193-2201.
56. Roth L, MacDonald JK, McDonald JWD, Chande N (2012) Sargramostim (GM-CSF) for induction of remission in Crohn's disease: A cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials. Inflamm Bowel Dis 18(7):1333-1339.
57. Burt RK, et al. (2010) Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: Longterm follow-up. Blood 116(26):6123-6132.